Posted on Leave a comment

Inbiotec Amber in the Master in Aesthetic Medicine of the Complutense University of Madrid

Inbiotec Amber in the Master in Aesthetic Medicine of the Complutense University of Madrid

The IT Pharma injectable combining succinic acid with hyaluronic acid was present in the practical workshops of the Master in Aesthetic, Regenerative and Anti-ageing Medicine of the Complutense University of Madrid.

During the workshop, Doctor Luis De Sola Semería, the Academic Coordinator of the Master, gave a number of demonstrations of the different facial mesotherapy techniques and products.

In the words of the doctor, “Innovation does not consist in developing new techniques or products separately, but using them in combination in order to get the best result. With Inbiotec Amber, we are seeking to provide the hydration of hyaluronic acid to the skin while at the same time achieving an antioxidant and anti-aging effect thanks to the synergy with succinic acid”.

Doctor De Sola highlighted the unique characteristics of AMBER, adding that “there are few innovations in the field of facial mesotherapy, which means that it is extremely interesting to work with a product such as Amber, thanks to its capacity to combine the traditional hydration of hyaluronics with the succinic antioxidant and protective action against free radicals. It is of great interest to our students to learn about these innovations in the sector and to know how to apply them throughout their professional career”.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Inbiotec Medical Devices, the new line of healthcare products developed by the IT Pharma group, is bringing its first product to market: Inbiotec Amber, a new injectable comprising 1.1% hyaluronic acid and 1.6% succinic acid. In a paper entitled: A new concept in mesotherapy: Discover the benefits of succinic acid, Doctor Latorre will explain the benefits of this active ingredient sourced from amber.

With this new line of healthcare products for aestheticians and dermatologists, IT Pharma aims to provide professionals with a safe, innovative product that stands out due to its combination of top quality ingredients.

The presentation is set to take place on Friday 22nd in Malaga, Conference Room 1 and will count on the presence of Dr. Pilar Garcia-Las Heras as moderator.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment